MICAELA KUBE: Open Payments
NPI 1497425904 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,615 in 251 payments from 19 companies in 2025. Trend: 2023 $2,664 · 2024 $3,642 · 2025 $3,615
Food & beverage: $3,408Education: $207
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $525 |
| Regeneron Healthcare Solutions, Inc. | 17 | $443 |
| Novartis Pharmaceuticals Corporation | 26 | $345 |
| Incyte Corporation | 29 | $294 |
| Amgen Inc. | 16 | $267 |
| Galderma Laboratories, L.P. | 27 | $266 |
| Janssen Biotech, Inc. | 12 | $260 |
| Journey Medical Corporation | 13 | $199 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 14 | $180 |
| E.R. Squibb & Sons, L.L.C. | 7 | $161 |
Products named: DUPIXENT, SKYRIZI, OPZELURA, TREMFYA, OTEZLA, COSENTYX, Cabtreo, RINVOQ.
Industry payments across NY — which companies pay providers there.
